In contrast, non-stimulant medications (primarily based on atomoxetine) showed a trend of risk reduction, though not reaching statistical significance [ 14 , 16 ].
← all excerpts
Guanfacine as a Treatment Option for Persistent Mental Restlessness and Deliberate Self-harm Thoughts in a Patient with Attention-deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Borderline Personality Disorder, and Post-traumatic Stress Disorder: Case Report.
1
—
—